Agarwal 2010.

Study characteristics
Methods	Study design Parallel RCT Time frame: not reported Duration of follow‐up: 6 months Country: India Setting: single centre
Participants	Study characteristics Inclusion criteria: children with initial episode of INS Exclusion criteria: not reported Baseline characteristics Number: intervention group (22); control group (20) Mean age ± SD (years): not reported Gender: not reported
Interventions	Intervention group Deflazacort (dose and duration not reported) Control group Prednisolone (dose and duration not reported)
Outcomes	Outcomes relevant to this review Remission at 2 and 6 weeks BMD
Notes	Additional information Abstract‐only publication
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Low risk	Block randomisation
Allocation concealment (selection bias)	Unclear risk	Insufficient information to permit judgement
Blinding of participants and personnel (performance bias) All outcomes	High risk	Open‐label study
Blinding of outcome assessment (detection bias) All outcomes	High risk	Open‐label study
Incomplete outcome data (attrition bias) All outcomes	Unclear risk	Insufficient information to permit judgement
Selective reporting (reporting bias)	Unclear risk	Not all prespecified outcomes mentioned but only abstract available
Other bias	Unclear risk	insufficient information to permit judgement